Background The association of prior bariatric surgery (BS) with infection rate and prognosis
of coronavirus disease 2019 (COVID-19) remains unclear. We conducted a meta-analysis of …

Obesity represents an independent risk factor for the development of chronic kidney disease
(CKD), leading to specific histopathological alterations, known as obesity-related …

Global obesity epidemics impacts human health and causes obesity-related illnesses,
including the obesity-related kidney and liver diseases. UTX, a histone H3K27 demethylase …

The SELECT trial previously reported a 20% reduction in major adverse cardiovascular
events with semaglutide (n= 8,803) versus placebo (n= 8,801) in patients with …

La enfermedad renal diabética, frecuente en pacientes con diabetes mellitus tipo 2, se
asocia con un marcado incremento de la morbimortalidad, especialmente cardiovascular, y …

The recently proposed nomenclature change from non-alcoholic fatty liver disease to
metabolic dysfunction-associated fatty liver disease (MAFLD) has resulted in the reappraisal …

The prevalence of obesity, a preventable and reversible condition with a high impact on
health, continues to rise, especially after the COVID-19 pandemic. Severe overweight is well …

Abstract Treatment for obesity in patients with CKD englobes a wide range of options, from
lifestyle modification to bariatric surgery. Weight loss improves metabolic parameters and …

Diabetic kidney disease, a common complication in patients with type 2 diabetes mellitus, is
associated with a markedly increased morbidity and mortality, especially of cardiovascular …

Objective: To examine the renoprotective effects of metabolic surgery in patients with
established chronic kidney disease (CKD). Background: The impact of metabolic surgery …